IRGI Inveresk Research Grp. (MM)

Inveresk Research Announces Fourth Quarter and Full Year 2003 Earnings Release and Webcast Conference Call on Tuesday, February 3, 2004 at 10:00 a.m. EST CARY, N.C., Jan. 8 /PRNewswire-FirstCall/ -- Inveresk Research Group, Inc. will be announcing its fourth quarter and full year earnings results for the fiscal year ended December 31, 2003, after the market closes on Monday, February 2, 2004. Management of the company will host a conference call to discuss these results on Tuesday, February 3, 2004, at 10:00 a.m. Eastern Standard Time. Presenting from the company will be Walter Nimmo, President and Chief Executive Officer and Paul Cowan, Chief Financial Officer. The conference call will be webcast live and will also be available for replay two hours after the completion of the call until 5:00 pm EST on Tuesday, February 10, 2004. To access the webcast, visit the Company's web site at http://www.inveresk.com/. Inveresk Research is a leading provider of drug development services to companies in the pharmaceutical and biotechnology industries. Through its pre-clinical and clinical business segments, the Company offers a broad range of drug development services, including pre-clinical safety and pharmacology evaluation services, laboratory sciences services and clinical development services. Inveresk Research is one of a small number of drug development services companies currently providing a comprehensive range of pre-clinical and clinical development services on a worldwide basis. The Company's client base includes major pharmaceutical companies in North America, Europe and Japan, as well as many biotechnology and specialty pharmaceutical companies. For more information on Inveresk Research, visit the Company's web site at http://www.inveresk.com/. DATASOURCE: Inveresk Research Group, Inc. CONTACT: Matt Dallas of Financial Dynamics, +1-212-850-5627, , for Inveresk Research Group, Inc. Web site: http://www.inveresk.com/

Copyright